{
    "organizations": [],
    "uuid": "d9abd89d94ce34ef8c0d93ce5550115736cbb010",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-madrigal-pharmaceuticals-reports-q/brief-madrigal-pharmaceuticals-reports-qtrly-loss-per-share-of-0-45-idUSASC0A0DH",
    "ord_in_thread": 0,
    "title": "BRIEF-Madrigal Pharmaceuticals Reports Qtrly Loss Per Share Of $0.45",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8 (Reuters) - Madrigal Pharmaceuticals Inc:\n* MADRIGAL PHARMACEUTICALS REPORTS 2018 FIRST QUARTER FINANCIAL RESULTS AND REVIEWS KEY CLINICAL ACHIEVEMENTS\n* QTRLY LOSS PER SHARE $0.45 * Q1 EARNINGS PER SHARE VIEW $-0.78 â€” THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-08T18:55:00.000+03:00",
    "crawled": "2018-05-09T12:25:27.015+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "madrigal",
        "pharmaceutical",
        "inc",
        "madrigal",
        "pharmaceutical",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "review",
        "key",
        "clinical",
        "achievement",
        "qtrly",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}